Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
- PMID: 7769728
- PMCID: PMC189210
- DOI: 10.1128/JVI.69.7.4582-4586.1995
Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
Abstract
Productive, spreading infection of peripheral blood lymphocytes (PBL) with human immunodeficiency virus type 1 (HIV-1) requires the viral protein Vif. To study the requirement for vif in this system, we infected PBL with a phenotypically complemented HIV-1 clone mutated in vif. Progeny virus was produced which was noninfectious in PBL but replicated in SupT1 cells. Analysis of metabolically labeled proteins of sedimentable extracellular particles made in PBL by radioimmunoprecipitation with either serum from a patient with AIDS or a monoclonal antibody reactive with HIV-1 Gag proteins revealed that vif-negative but not wild-type particles carry higher levels of p55, p41, and p38 Gag-specific proteins compared with those of p24. Similar results were obtained with sucrose-purified virions. Our data indicate that vif plays a role in Gag protein processing or in incorporation of processed Gag products into mature virions. The presence of unprocessed precursor Gag polyprotein (Pr55gag) and other Gag processing intermediates in PBL-derived vif-negative extracellular particles may contribute to the reduced infectivity of this virus.
Similar articles
-
Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells.J Virol. 1997 Mar;71(3):2473-7. doi: 10.1128/JVI.71.3.2473-2477.1997. J Virol. 1997. PMID: 9032385 Free PMC article.
-
Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.J Virol. 2001 Jun;75(12):5504-17. doi: 10.1128/JVI.75.12.5504-5517.2001. J Virol. 2001. PMID: 11356958 Free PMC article.
-
Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes.J Virol. 1999 Apr;73(4):2667-74. doi: 10.1128/JVI.73.4.2667-2674.1999. J Virol. 1999. PMID: 10074112 Free PMC article.
-
Cell-dependent function of HIV-1 Vif for virus replication (Review).Int J Mol Med. 1999 May;3(5):473-6. doi: 10.3892/ijmm.3.5.473. Int J Mol Med. 1999. PMID: 10202177 Review.
-
The Vif protein of human immunodeficiency virus type 1 (HIV-1): enigmas and solutions.Curr Med Chem. 2004 Jan;11(2):221-31. doi: 10.2174/0929867043456124. Curr Med Chem. 2004. PMID: 14754418 Review.
Cited by
-
APOBEC4 Enhances the Replication of HIV-1.PLoS One. 2016 Jun 1;11(6):e0155422. doi: 10.1371/journal.pone.0155422. eCollection 2016. PLoS One. 2016. PMID: 27249646 Free PMC article.
-
Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag.Vaccine. 2007 Feb 19;25(9):1634-46. doi: 10.1016/j.vaccine.2006.11.004. Epub 2006 Nov 15. Vaccine. 2007. PMID: 17145123 Free PMC article.
-
Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.J Biol Chem. 2003 Feb 21;278(8):6596-602. doi: 10.1074/jbc.M210164200. Epub 2002 Dec 11. J Biol Chem. 2003. PMID: 12480936 Free PMC article.
-
HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.Blood. 2007 Aug 15;110(4):1207-14. doi: 10.1182/blood-2006-06-028175. Epub 2007 May 18. Blood. 2007. PMID: 17513617 Free PMC article.
-
Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes.J Virol. 2001 Sep;75(17):7925-33. doi: 10.1128/jvi.75.17.7925-7933.2001. J Virol. 2001. PMID: 11483737 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous